ArticlePoultry science2026
Resveratrol protects against triclosan-induced impairment of colonic barrier function in chickens.
Article in Poultry science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Triclosan (TCS) is a widely used antimicrobial agent, and chronic exposure has been reported to impair intestinal barrier function and induce oxidative stress and inflammation. Resveratrol (RSV), a natural polyphenolic compound with antioxidant and anti-inflammatory properties, may protect against TCS-induced intestinal injury. This study investigated the protective effects of RSV on TCS-induced colonic damage in chickens and the underlying mechanisms. In a 4-week trial, 100 10-week-old chickens were randomly assigned to five groups (n = 20 per group): control (CON), solvent control (VCON), TCS (150 mg/kg), RSV (400 mg/kg), and TCS+RSV. To evaluate the protective effects, we measured colonic morphology, barrier-related proteins, serum markers, oxidative stress indicators, and mitochondrial biogenesis and dynamics signaling. Data were analyzed using one-way ANOVA, and significance was set at P < 0.05. Results showed TCS significantly damaged colonic structure and impaired barrier function, alongside increased inflammation and mitochondrial dysregulation (P < 0.05). RSV supplementation markedly mitigated these effects by restoring morphology, upregulating tight junction proteins and MUC2, and reducing serum d-lactate and DAO levels. Mechanistically, RSV suppressed NLRP3 inflammasome activation, enhanced antioxidant capacity via the Nrf2/HO-1 pathway, and normalized the SIRT1/PGC-1α axis to preserve mitochondrial homeostasis (P < 0.05). These findings suggest that RSV may serve as a potential dietary strategy to protect intestinal health in poultry under environmental contaminant exposure.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.